Results 121 to 130 of about 149,596 (212)

Development of CAR Exosomes Targeting FAP for the Treatment of Intrauterine Adhesion

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 5, May 2026.
ABSTRACT Engineered extracellular vesicles (EVs) have emerged as promising cell‐free platforms for immunomodulation and tissue repair. In this study, we generated EVs derived from chimeric antigen receptor (CAR) T cells targeting fibroblast activation protein (FAP) and investigated their biological and therapeutic functions.
Wenyan Fu   +8 more
wiley   +1 more source

Phages & antibiotic resistance: are the most abundant entities on earth ready for a comeback? [PDF]

open access: yes, 2018
Bacteriophages, which lost out to antibiotic therapy in the past, may be poised to make a comeback. Once discarded because of their narrow activity spectrum, it can now be viewed as a major advantage that these intracellular, self-replicating entities ...
Hill, Colin, Mills, Susan, Ross, R. Paul
core   +1 more source

Viable but Nonculturable State, a Survival Strategy for Salmonella in Aquatic Environments

open access: yesWater and Environment Journal, Volume 40, Issue 2, Page 183-202, May 2026.
Transition of Salmonella from a culturable state to a viable but nonculturable state under various environmental stresses and current methods for detecting viable Salmonella in environmental samples. ABSTRACT In the relentless battle for survival, Salmonella has evolved mechanisms to withstand harsh conditions such as extreme temperatures, fluctuating ...
Sanelisiwe Thinasonke Duze   +3 more
wiley   +1 more source

Enzyme‐Assisted Synthesis and In Vitro Characterization of Bifunctional PCSK9 Inhibitors

open access: yesChemBioChem, Volume 27, Issue 7, 14 April 2026.
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is an important therapeutic target for lowering cholesterol. Here, we report the assembly of a bifunctional molecule combining a PCSK9‐binding peptide with an asialoglycoprotein receptor (ASGPR) ligand.
Yuhui Zhang   +8 more
wiley   +1 more source

A New Approach for Phage Cocktail Design in the Example of Anti-Mastitis Solution

open access: yesPathogens
The studies on phage therapy have shown an overall protective effect of phages in bacterial infections, thus providing an optimistic outlook on the future benefits of phage-based technologies for treating bacterial diseases.
Daria Królikowska   +9 more
doaj   +1 more source

Phage sensitivity and prophage carriage in Staphylococcus aureus isolated from foods in Spain and New Zealand [PDF]

open access: yes, 2016
Bacteriophages (phages) are a promising tool for the biocontrol of pathogenic bacteria, including those contaminating food products and causing infectious diseases.
Billington, Craig   +7 more
core   +1 more source

Ackermannviridae bacteriophage against carbapenem-resistant Klebsiella pneumoniae of capsular type 64

open access: yesFrontiers in Microbiology
Lytic bacteriophages (phages) are promising clinically viable therapeutic options against carbapenem-resistant Klebsiella pneumoniae (CRKP). In China, the predominant strains are those assigned to sequence type 11 and capsular type 64 (ST11-KL64).
Juan Li   +10 more
doaj   +1 more source

Phages anti-Pseudomonas aeruginosa pour le traitement des plaies brûlées infectées. Evaluation in vitro et résultats préliminaires de la mise au point d'un modèle ex vivo. [PDF]

open access: yes, 2015
Les bactériophages sont des virus spécifiques aux bactéries. Ils ont été découverts au début du 20ème siècle en France. Les premières études les concernant comme thérapie pour les infections bactériennes ont été conduites par Felix D'He ...
AL-DOUROBI, K.
core  

Platelets promote macrophage polarization toward pro-inflammatory phenotype and increase survival of septic mice [PDF]

open access: yes, 2019
We investigated the contribution of human platelets to macrophage effector properties in the presence of lipopolysaccharide (LPS), as well as the beneficial effects and time frame for platelet transfusion in septic animals.
Carestia, Agostina   +9 more
core   +1 more source

FORMULATING PHAGE COCKTAILS AS ADJUVANT THERAPY IN CARBAPENEM-RESISTANT PSEUDOMONAS AERUGINOSA

open access: yesOpen Respiratory Archives
Introduction: Phage-antibiotic synergy (PAS) results in bacterial killing beyond the efficacy of either agent alone. Although the main candidates for therapeutic PAS are lytic phages, temperate phages have been re-evaluated in light of PAS.
Viviane de Cássia Oliveira   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy